Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1082846 | Journal of Clinical Epidemiology | 2010 | 10 Pages |
Abstract
These examples highlight both the challenges and opportunities of pharmacogenomics. First, establishing a valid association between a genetic variation and drug response; second, doing so for a clinically meaningful outcome; and third, providing solid evidence or rationale for improvement in patient outcomes compared with current standard of care.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Nita A. Limdi, David L. Veenstra,